Overnight Offering: We are a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical need.
Last Closing Price
March 4, 2021
LADENBURG, THALMANN & CO., INC.
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Salarius Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277